Pharma Professionals Must-Attend: 2025 Nanjing Industry Summit Focused on Pharma Enterprise Transformation and Unlocking Innovative Growth Opportunities

The “tale of two extremes” in the pharmaceutical industry in 2025 is reshaping the survival logic of every company:

• Under Intense Policy Pressure, Companies Struggle to Survive:Volume-based procurement (VBP) is evolving from "normalization" to "refinement," while the access standards for National Reimbursement Drug List (NRDL) negotiations continue to rise. The impending launch of VBP for proprietary Chinese medicines has further heightened anxiety among many enterprises. With compliance regulations tightening and the traditional kickback-driven sales model completely phased out, companies face mounting constraints in product development and marketing, leading to sustained compression of profit margins.

• Amid the Wave of Innovation, Opportunities Lie Hidden:Early this year, Document No. 53 issued by the State Council propelled reforms in the regulation of pharmaceuticals and medical devices. The National Healthcare Security Administration and the National Medical Products Administration successively introduced policies to support innovation, while biomedical industrial parks across various regions implemented supportive measures one after another. “Innovation” is no longer an optional choice but a matter of survival. Meanwhile, innovative drugs and high-end formulations have become the focal points of the market. Innovative traditional Chinese medicine (TCM) drugs are accelerating their development thanks to policy dividends, and niche sectors such as the domestic substitution of medical devices, medical aesthetics and anti-aging, and the silver economy are experiencing explosive growth.

• Amidst a Diverging Landscape, Transformation Is Urgent:Healthcare insurance reforms and volume-based procurement have fundamentally shattered traditional growth paradigms. Generic chemical drug manufacturers must rely on cost reduction and efficiency enhancement to survive, while companies with innovative capabilities that can precisely target niche segments are already seizing new market high grounds. The industry is shifting from a “product-centric” to a “health-centric” model; those who fail to proactively transform will inevitably be eliminated.

Why is this forum hailed as a “timely rain” for pharmaceutical professionals? Because it precisely addresses the industry’s most urgent needs!

• Cracking Transformation Anxiety:Amidst shifting policies and market fragmentation, many enterprises find themselves trapped in a “reactive” dilemma—uncertain how to navigate new centralized procurement regulations, unclear about the direction of innovation, and lacking the know-how to integrate upstream and downstream resources. This forum is designed precisely to address these pain points, enabling companies to shift from “confused bandwagoning” to “proactive strategic planning.”

• Connecting with the Industry's Golden Node:The forum is scheduled for November 17–18, 2025, coinciding with the eve of the 91st China National Pharmaceutical Trade Fair. By hosting the event in Nanjing, it can directly leverage the industry clustering effect of the Trade Fair. Attendees will be able to gain valuable insights and connect with resources at the forum, while seamlessly transitioning to the Trade Fair, thereby achieving a one-stop experience of “learning + collaboration + site visits” with maximum efficiency.

• Integrating Resources Across the Entire Industry Chain:The pharmaceutical industry’s ecosystem is currently undergoing restructuring, making solo endeavors obsolete. As the organizer, Zhongrui Pharmaceutical Business School has joined forces with Beijing Zhongrui Xinkang series companies, Qiantuhui, and Yaorongquan,Yaozhi...and dozens of other industry institutions, covering the entire value chain from R&D, manufacturing, and marketing to compliance and capital, all to build an ecosystem platform for attendees that fosters “resource connectivity and experience sharing.”

What Are the “Key Takeaways” from This Forum? After Reviewing These Highlights, You Definitely Won’t Want to Miss It!

High in Both Scale and Specifications:

• Time and Location:November 17–18, 2025，Nanjing The Lalu Hotel(Convenient transportation, premium environment)

• Attendee Lineup:60+renowned experts (including former officials from the National Healthcare Security Administration and the National Medical Products Administration, as well as leading industry scholars),1200 +Pharmaceutical company executives, andNear100 Booths(Premium Booth + Standard Booth), whether for academic exchange or business collaboration, we have you covered.

• Organizers and Supporters:Organized by Zhongrui Pharmaceutical Business School, co-organized by the Beijing Zhongrui Xinkang series of companies, and co-sponsored by Qiantuhui, PharmaCircle, and Yaozhi Network, with new media support from Badian Health Hub and PharmaCube, the platform boasts substantial strength and guaranteed resources.

Policy Decoded, Pitfall-Free:Experts from the National Healthcare Security Administration and the National Medical Products Administration provide in-depth interpretations of the new regulations on centralized procurement, strategies for breakthroughs in the centralized procurement of proprietary Chinese medicines, and the new model for healthcare security negotiations. This helps you thoroughly grasp key policy points and identify the greatest room for development within a compliant framework.

Innovative Breakthroughs, Strategic Thinking:From AI in healthcare and innovative drug R&D to omnichannel growth both inside and outside hospitals, as well as innovation in traditional Chinese medicine, each topic offers actionable strategies—focusing not on empty theory, but on practical implementation.

Resource Matching to Foster Collaboration:The forum covers companies across the entire industry chain, including CROs, digital health services, medical aesthetics, and medical devices. It also features the Zhongrui Alumni Networking Dinner and a Resource Matchmaking Conference, enabling you to effortlessly connect with potential partners and secure business collaborations.

2025: The One-and-Only Transformation Window for the Pharmaceutical Industry! If you aim to alleviate the pressures brought by volume-based procurement and national reimbursement negotiations, seize innovation opportunities in traditional Chinese medicine, medical aesthetics, and medical devices, and connect with over 1,200 pharmaceutical executives, then this forum in Nanjing on November 17–18 is an industry event you absolutely cannot miss!

Registration is now open. Scan the QR code at the end of this article to secure your spot and join 1,500+ healthcare professionals in discovering new pathways for growth amidst transformation!